Delivery Order SPE2DR25D1202-SPE2DR26F72VE
Award Date 12/8/25
Potential Completion Date 12/9/25
Potential Value $5.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid-based injection used for osteoarthritis pain management. This firm fixed-price delivery order, valued at $2,057.32, represents a competitive award with no set-aside designation and is scheduled for completion by September 15, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a $20.86K delivery order to AmerisourceBergen Drug Corp for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid-based injectable treatment for osteoarthritis. This competitive delivery order, issued on September 26, 2025, with a completion date of September 29, 2025, represents a firm fixed-price transaction with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a $8,624.13 delivery order to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a hyaluronic acid-based intra-articular injection used for osteoarthritis pain management. Issued on September 2, 2025, with completion targeted for September 3, 2025, this firm fixed price delivery order was competitively awarded without set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid-based intra-articular injection used for osteoarthritis pain management. This firm fixed-price delivery order carries a ceiling value of $16,330.08 and is scheduled for completion by December 11, 2025. The contract was competitively awarded without set-aside designation and represents a child delivery order under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 6, 2025, for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid injection used for osteoarthritis treatment. This firm fixed price delivery order, valued at $5,019.40, represents a competitive award with no set-aside designation and is scheduled for completion by August 7, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency valued at $10,419.84 for Synvisc-One Syringe 6ML, a hyaluronic acid-based joint injection used to treat osteoarthritis pain. The contract, awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, is a firm fixed price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid-based injectable treatment for osteoarthritis. This firm fixed-price delivery order, valued at $16,171.02, is not set-aside and represents a competitive award under the company's existing contract vehicles with DLA. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $3,484.68 to AmerisourceBergen Drug Corp for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid-based injectable treatment for osteoarthritis. The contract, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,808.18 to AmerisourceBergen Drug Corp for Synvisc-One Syringes (6mL), a hyaluronic acid-based injectable treatment for osteoarthritis. This firm fixed-price, competitively awarded delivery order was issued on September 18, 2025, with an ultimate completion date of September 19, 2025, and will be performed at the awardee's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid injection used for knee osteoarthritis treatment. This non-set-aside, competitively awarded contract carries a ceiling value of $11,322.76 under a firm fixed price arrangement, with an ultimate completion date of August 22, 2025. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken,...